These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29713480)

  • 21. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
    Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe hypoglycemia and hip fracture in patients with type 2 diabetes: a nationwide population-based cohort study.
    Hung YC; Lin CC; Chen HJ; Chang MP; Huang KC; Chen YH; Chen CC
    Osteoporos Int; 2017 Jul; 28(7):2053-2060. PubMed ID: 28374044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study.
    Hong EG; Min KW; Lim JS; Ahn KJ; Ahn CW; Yu JM; Kim HS; Kim HJ; Kim W; Kim DH; Jang HC
    Adv Ther; 2024 May; 41(5):1967-1982. PubMed ID: 38512540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-reported non-severe hypoglycaemic events in Europe.
    Östenson CG; Geelhoed-Duijvestijn P; Lahtela J; Weitgasser R; Markert Jensen M; Pedersen-Bjergaard U
    Diabet Med; 2014 Jan; 31(1):92-101. PubMed ID: 23796113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-Reported Hypoglycemia in Insulin-Treated Patients with Diabetes: Results from the Philippine Cohort of the International Operations Hypoglycemia Assessment Tool (IO HAT) Study.
    Mirasol R; Nicodemus N; Jain A; Gadekar AV; Yu-Gan S
    J ASEAN Fed Endocr Soc; 2018; 33(1):12-21. PubMed ID: 33442106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient-reported frequency, awareness and patient-physician communication of hypoglycaemia in Belgium.
    Peene B; D'Hooge D; Vandebrouck T; Mathieu C
    Acta Clin Belg; 2014 Dec; 69(6):439-45. PubMed ID: 25212241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain.
    Morales C; de Luis D; de Arellano AR; Ferrario MG; Lizán L
    Diabetes Ther; 2015 Dec; 6(4):593-610. PubMed ID: 26589521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries.
    Geelhoed-Duijvestijn PH; Pedersen-Bjergaard U; Weitgasser R; Lahtela J; Jensen MM; Östenson CG
    J Med Econ; 2013 Dec; 16(12):1453-61. PubMed ID: 24144009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Basal insulin glargine using a basal-bolus regimen in a common clinical practice: observational, non-interventional, multicenter, national project LINDA (Lantus in daily practice - safety and efficacy in basal bolus regimen)].
    Zďarská DJ; Brož J; Křivská B; Rušavý Z; Kvapil M
    Vnitr Lek; 2014 Sep; 60(9):712-9. PubMed ID: 25294758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individual and societal consequences of hypoglycemia: A cross-sectional survey.
    Dømgaard M; Bagger M; Rhee NA; Burton CM; Thorsteinsson B
    Postgrad Med; 2015 Jun; 127(5):438-45. PubMed ID: 25971530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveys.
    Fulcher G; Singer J; Castañeda R; Fraige Filho F; Maffei L; Snyman J; Brod M
    J Med Econ; 2014 Oct; 17(10):751-61. PubMed ID: 25061766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies.
    Xie L; Wei W; Pan C; Baser O
    J Med Econ; 2013 Sep; 16(9):1137-45. PubMed ID: 23859434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study.
    Giorda CB; Ozzello A; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Lucisano G; Nicolucci A; Rossi MC;
    Acta Diabetol; 2015 Oct; 52(5):845-53. PubMed ID: 25670242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world patient-reported rates of non-severe hypoglycaemic events in Germany.
    Kulzer B; Seitz L; Kern W
    Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):167-72. PubMed ID: 24643694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoglycaemia in adults with insulin-treated diabetes in the UK: self-reported frequency and effects.
    Frier BM; Jensen MM; Chubb BD
    Diabet Med; 2016 Aug; 33(8):1125-32. PubMed ID: 26248501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of Patients with Type-1 or Type-2 Diabetes Receiving Insulin Glargine U300: An Analysis of 7268 Patients Based on the DPV and DIVE Registries.
    van Mark G; Lanzinger S; Sziegoleit S; Putz FJ; Durmaz M; Borscheller M; Danne T; Seufert J; Holl RW; Bramlage P
    Adv Ther; 2019 Jul; 36(7):1628-1641. PubMed ID: 31119688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System.
    Parekh W; Streeton SE; Baker-Knight J; Montagnoli R; Nicoziani P; Marchesini G
    Diabetes Ther; 2018 Jun; 9(3):1037-1047. PubMed ID: 29600505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of insulin glargine versus NPH insulin for the treatment of Type 2 diabetes mellitus, modeling the interaction between hypoglycemia and glycemic control in Switzerland.
    Brändle M; Azoulay M; Greiner RA
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):217-30. PubMed ID: 21329624
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.